SCHEMBL16634627

SCHEMBL16634627

O=C(O)c1ccc(-n2c(=O)[nH]c3ccccc32)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 3/20 0.50
▸ TNKS O95271 1/20 0.49
▸ LMNA P02545 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.44
▸ RORC P51449 2/20 0.44
▸ GSK3B P49841 1/20 0.44
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43
▸ RARG P13631 1/20 0.43
▸ HSP90AA1 P07900 4/20 0.43
▸ DAO P14920 1/20 0.43
▸ GABRP O00591 1/20 0.41
▸ GABRD O14764 1/20 0.41
▸ GABRA1 P14867 1/20 0.41
▸ GABRB1 P18505 1/20 0.41
▸ GABRG2 P18507 1/20 0.41
▸ GABRB3 P28472 1/20 0.41
▸ GABRA5 P31644 1/20 0.41
▸ GABRA3 P34903 1/20 0.41
▸ GABRA2 P47869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5956569 0.85 RAB9A (0.55) AURKATNKSLMNAKDM4EGABRP
SCHEMBL16456379 0.79 AURKA (0.53) AURKATNKSLMNAKDM4ECDK5
SCHEMBL16634744 0.79 L3MBTL1 (0.55) AURKATNKSLMNAKDM4EGSK3B
SCHEMBL16455944 0.76 TNKS (0.49) AURKATNKSLMNAKDM4ECDK5
SCHEMBL30423157 0.75 GABRP (0.53) AURKATNKSLMNAKDM4ECDK5
SCHEMBL4161172 0.75 GABRP (0.53) AURKATNKSLMNAKDM4ECDK5
SCHEMBL30792661 0.74 AURKA (0.49) AURKALMNAHSP90AA1MAPT
SCHEMBL28489192 0.73 AURKA (0.48) AURKATNKSLMNAKDM4ECDK5
SCHEMBL16634626 0.72 HSP90AA1 (0.54) AURKAKDM4ERORCHSP90AA1DAO
SCHEMBL21463397 0.72 LMNA (0.49) AURKATNKSLMNAKDM4ECDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 — — WO disclosed
Send feedback